# reload+after+2024-01-20 05:47:02.292159
address1§18575 Jamboree Road
address2§Suite 275-S
city§Irvine
state§CA
zip§92612
country§United States
phone§858 283 0280
website§https://reneopharma.com
industry§Biotechnology
sector§Healthcare
longBusinessSummary§Reneo Pharmaceuticals, Inc., a clinical-stage pharmaceutical company, focuses on the development and commercialization of therapies for patients with rare genetic mitochondrial diseases. Its lead product candidate is REN001, a potent and selective agonist of the peroxisome proliferator-activated receptor delta that is in clinical development for genetic mitochondrial diseases comprising primary mitochondrial myopathies and long-chain fatty acid oxidation disorders. Reneo Pharmaceuticals, Inc. was incorporated in 2014 and is headquartered in Irvine, California.
fullTimeEmployees§55
companyOfficers§[{'maxAge': 1, 'name': 'Mr. Michael G. Grey', 'age': 70, 'title': 'Founder & Executive Chairman', 'yearBorn': 1953, 'fiscalYear': 2022, 'totalPay': 100000, 'exercisedValue': 0, 'unexercisedValue': 0}, {'maxAge': 1, 'name': 'Mr. Gregory J. Flesher', 'age': 53, 'title': 'President, CEO & Director', 'yearBorn': 1970, 'fiscalYear': 2022, 'totalPay': 800452, 'exercisedValue': 0, 'unexercisedValue': 0}, {'maxAge': 1, 'name': 'Mr. Michael P. Cruse', 'age': 51, 'title': 'Chief Operating Officer', 'yearBorn': 1972, 'fiscalYear': 2022, 'totalPay': 535474, 'exercisedValue': 0, 'unexercisedValue': 0}, {'maxAge': 1, 'name': 'Ms. Ashley F. Hall J.D.', 'age': 51, 'title': 'Chief Development Officer', 'yearBorn': 1972, 'fiscalYear': 2022, 'totalPay': 661554, 'exercisedValue': 0, 'unexercisedValue': 0}, {'maxAge': 1, 'name': 'Ms. Jennifer P. Lam', 'title': 'Senior VP of Finance, Principal Financial & Accounting Officer', 'fiscalYear': 2022, 'exercisedValue': 0, 'unexercisedValue': 0}, {'maxAge': 1, 'name': 'Dr. Alejandro  Dorenbaum M.D.', 'age': 62, 'title': 'Chief Medical Officer', 'yearBorn': 1961, 'fiscalYear': 2022, 'totalPay': 477650, 'exercisedValue': 0, 'unexercisedValue': 0}, {'maxAge': 1, 'name': 'Ms. Lynn  Purkins Ph.D.', 'title': 'Senior Vice President of Global Development', 'fiscalYear': 2022, 'exercisedValue': 0, 'unexercisedValue': 0}]
auditRisk§9
boardRisk§9
compensationRisk§9
shareHolderRightsRisk§8
overallRisk§9
governanceEpochDate§1704067200
compensationAsOfEpochDate§1672444800
maxAge§86400
priceHint§4
payoutRatio§0.0
beta§0.235
currency§USD
dateShortInterest§1702598400
forwardEps§-1.11
exchange§NGM
quoteType§EQUITY
shortName§Reneo Pharmaceuticals, Inc.
longName§Reneo Pharmaceuticals, Inc.
firstTradeDateEpochUtc§1617888600
timeZoneFullName§America/New_York
timeZoneShortName§EST
uuid§c7de8d52-ede8-3468-aef4-c60e74653234
gmtOffSetMilliseconds§-18000000
targetHighPrice§4.0
targetLowPrice§1.0
targetMeanPrice§2.13
targetMedianPrice§1.65
recommendationMean§3.1
recommendationKey§hold
numberOfAnalystOpinions§6
quickRatio§9.262
grossMargins§0.0
ebitdaMargins§0.0
trailingPegRatio§None
